Cytokinetics (CYTK) Short Interest Ratio & Short Volume → Your 'AI Income Playbook' Awaits... (From The Oxford Club) (Ad) Free CYTK Stock Alerts $53.93 +1.22 (+2.31%) (As of 06/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Cytokinetics Short Interest DataCurrent Short Interest16,420,000 sharesPrevious Short Interest14,190,000 sharesChange Vs. Previous Month+15.72%Dollar Volume Sold Short$796.53 millionShort Interest Ratio7.2 Days to CoverLast Record DateMay 31, 2024Outstanding Shares104,850,000 sharesFloat Size110,480,000 sharesShort Percent of Float14.86%Today's Trading Volume1,182,895 sharesAverage Trading Volume2,965,736 sharesToday's Volume Vs. Average40% Short Selling Cytokinetics ? Sign up to receive the latest short interest report for Cytokinetics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCYTK Short Interest Over TimeCYTK Days to Cover Over TimeCYTK Percentage of Float Shorted Over Time Ad The Oxford ClubClaim Your FREE "AI Income Playbook" Now!Income expert Marc Lichtenfeld has a special gift reserved just for you... It's his brand-new "AI Income Playbook" - and it's yours FREE!Click here now to claim your FREE copy of Marc's AI playbook. Cytokinetics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/202416,420,000 shares $796.53 million +15.7%14.9%7.2 $48.51 5/15/202414,190,000 shares $858.50 million +3.8%14.1%6.5 $60.50 4/30/202413,670,000 shares $838.24 million -2.6%13.5%7.2 $61.32 4/15/202414,040,000 shares $954.72 million +6.1%13.9%6.9 $68.00 3/31/202413,230,000 shares $927.56 million -10.6%13.3%4.2 $70.11 3/15/202414,800,000 shares $964.81 million +1.9%14.9%3.7 $65.19 Get the Latest News and Ratings for CYTK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cytokinetics and its competitors with MarketBeat's FREE daily newsletter. 2/29/202414,530,000 shares $1.05 billion +5.1%14.6%3.9 $72.24 2/15/202413,830,000 shares $1.09 billion +1.8%14.6%3.9 $78.56 1/31/202413,580,000 shares $1.06 billion -1.2%14.5%3.9 $78.13 1/15/202413,750,000 shares $1.18 billion -8.8%14.7%3.9 $85.60 12/31/202315,080,000 shares $1.26 billion +2.9%16.1%5.1 $83.49 12/15/202314,660,000 shares $528.79 million +9.0%15.7%6.7 $36.07 11/30/202313,450,000 shares $450.31 million -1.8%14.4%8.9 $33.48 11/15/202313,690,000 shares $449.44 million -3.1%14.6%10.1 $32.83 10/31/202314,130,000 shares $492.57 million +2.8%15.4%11.6 $34.86 10/15/202313,750,000 shares $470.39 million +5.3%15.0%13 $34.21 9/30/202313,060,000 shares $384.75 million +4.1%14.2%14.2 $29.46 9/15/202312,550,000 shares $429.59 million +8.1%13.7%15.7 $34.23 8/31/202311,610,000 shares $405.65 million +15.1%13.0%14.2 $34.94 8/15/202310,090,000 shares $330.04 million No Change11.3%12.4 $32.71 7/31/202310,090,000 shares $336.50 million -0.1%11.2%12.1 $33.35 7/15/202310,100,000 shares $352.79 million +1.5%11.3%11.8 $34.93 6/30/20239,950,000 shares $324.57 million +7.9%11.1%11.3 $32.62 6/15/20239,220,000 shares $326.76 million -2.5%10.3%10.2 $35.44 5/31/20239,460,000 shares $356.55 million +0.2%10.5%10.4 $37.69 5/15/20239,440,000 shares $367.69 million No Change10.5%9.4 $38.95 10/31/202211,340,000 shares $495.10 million -8.8%N/A9.9 $43.66 10/15/202212,440,000 shares $571.62 million +2.7%N/A10 $45.95 9/30/202212,110,000 shares $586.73 million +3.8%N/A9.5 $48.45 9/15/202211,670,000 shares $636.13 million -2.9%N/A7.7 $54.51 8/31/202212,020,000 shares $636.58 million -5.7%N/A8.1 $52.96 8/15/202212,740,000 shares $647.57 million +8.7%N/A9.2 $50.83 7/31/202211,720,000 shares $496.11 million -0.8%N/A8.6 $42.33 7/15/202211,810,000 shares $478.31 million +37.8%N/A9.4 $40.50 6/30/20228,570,000 shares $336.72 million +0.5%16.6%7.3 $39.29 6/15/20228,530,000 shares $350.67 million -2.0%16.5%10 $41.11 5/31/20228,700,000 shares $347.13 million -2.6%N/A10.1 $39.90 5/15/20228,930,000 shares $375.15 million +11.5%N/A9.6 $42.01 4/30/20228,010,000 shares $319.36 million +1.0%N/A7.9 $39.87 4/15/20227,930,000 shares $313.71 million +5.7%N/A7.9 $39.56Your "AI Income Playbook" Awaits... (Ad)Today, he wants to give you his "AI Income Playbook"... FREE of charge! Inside, you'll discover Marc's favorite AI dividend stocks... Complete with their names, ticker symbols, and full breakdown of their massive income potential.Click here now to claim your FREE copy of Marc's AI playbook. 3/31/20227,500,000 shares $276.08 million +3.7%N/A6.9 $36.81 3/15/20227,230,000 shares $245.39 million -13.1%N/A6.7 $33.94 2/28/20228,320,000 shares $293.86 million +1.2%N/A7.7 $35.32 2/15/20228,220,000 shares $308.91 million +4.2%N/A7.5 $37.58 1/31/20227,890,000 shares $261.87 million -1.5%N/A7.7 $33.19 1/15/20228,010,000 shares $264.33 million +0.8%N/A0 $33.00 12/31/20217,950,000 shares $362.36 million -9.1%N/A8.8 $45.58 12/15/20218,750,000 shares $337.84 million +1.0%N/A10.1 $38.61 11/30/20218,660,000 shares $340.68 million -5.8%N/A10.1 $39.34 11/15/20219,190,000 shares $360.25 million -9.8%N/A10.6 $39.20 10/29/202110,190,000 shares $355.73 million +5.2%N/A12.3 $34.91 10/15/20219,690,000 shares $357.46 million -7.7%N/A11.3 $36.89 9/30/202110,500,000 shares $375.27 million -1.8%N/A5.5 $35.74 9/15/202110,690,000 shares $360.25 million -5.4%N/A5.7 $33.70 8/31/202111,300,000 shares $372.56 million -1.0%N/A6.2 $32.97 8/13/202111,410,000 shares $366.83 million -4.3%N/A6.5 $32.15 7/30/202111,920,000 shares $353.79 million +32.4%N/A6.6 $29.68 7/15/20219,000,000 shares $173.88 million +10.2%N/A5.2 $19.32 6/30/20218,170,000 shares $161.68 million -5.4%12.2%10.8 $19.79 6/15/20218,640,000 shares $192.50 million -4.9%12.9%11.8 $22.28 5/28/20219,080,000 shares $198.22 million -9.6%13.6%11.2 $21.83 5/14/202110,040,000 shares $253.31 million +6.9%N/A10.6 $25.23 4/30/20219,390,000 shares $247.80 million +2.6%N/A10.2 $26.39 4/15/20219,150,000 shares $221.98 million +1.9%N/A0 $24.26 3/31/20218,980,000 shares $200.52 million -7.7%N/A9.6 $22.33 3/15/20219,730,000 shares $222.04 million +5.5%N/A10.1 $22.82 2/26/20219,220,000 shares $183.02 million +0.2%N/A9.2 $19.85 2/12/20219,200,000 shares $209.39 million -3.7%N/A9.8 $22.76 1/29/20219,550,000 shares $191 million -3.5%N/A9.3 $20.00 1/15/20219,900,000 shares $196.02 million +6.3%N/A9.6 $19.80 12/31/20209,310,000 shares $189.55 million +12.7%N/A7.4 $20.36 12/15/20208,260,000 shares $175.44 million -7.8%N/A4.8 $21.24 11/30/20208,960,000 shares $153.66 million +1.8%N/A5.4 $17.15 11/15/20208,800,000 shares $145.38 million -6.4%N/A5.5 $16.52 10/30/20209,400,000 shares $145.61 million +3.3%N/A6.1 $15.49 10/15/20209,100,000 shares $150.06 million +3.6%N/A6 $16.49 9/30/20208,780,000 shares $190.09 million +22.3%N/A5.7 $21.65 9/15/20207,180,000 shares $166.72 million -3.8%N/A7.6 $23.22 8/31/20207,460,000 shares $178.74 million +3.5%N/A8.2 $23.96 8/14/20207,210,000 shares $162.37 million -1.2%N/A8.3 $22.52 7/31/20207,300,000 shares $157.83 million -9.2%13.4%7.5 $21.62 7/15/20208,040,000 shares $224.16 million -1.7%14.8%8.2 $27.88 6/30/20208,180,000 shares $192.97 million +6.0%15.0%9.5 $23.59 6/15/20207,720,000 shares $167.76 million -6.3%14.2%8.9 $21.73 5/29/20208,240,000 shares $170.73 million +3.7%15.1%9 $20.72 5/15/20207,950,000 shares $172.04 million +1.9%14.6%8.1 $21.64 4/30/20207,800,000 shares $117.86 million -8.6%14.4%7.7 $15.11 4/15/20208,530,000 shares $118.82 million +8.5%15.7%9.2 $13.93 3/31/20207,860,000 shares $123.24 million +0.4%14.5%8.7 $15.68 3/13/20207,830,200 shares $108.76 million -6.1%14.4%10.5 $13.89Your "AI Income Playbook" Awaits... (Ad)Today, he wants to give you his "AI Income Playbook"... FREE of charge! Inside, you'll discover Marc's favorite AI dividend stocks... Complete with their names, ticker symbols, and full breakdown of their massive income potential.Click here now to claim your FREE copy of Marc's AI playbook. 2/28/20208,340,000 shares $82.82 million -7.2%15.3%9.3 $9.93 2/14/20208,990,000 shares $119.66 million +2.3%16.6%10.3 $13.31 1/31/20208,790,000 shares $123.68 million +3.8%16.3%8.6 $14.07 1/15/20208,470,000 shares $127.90 million -9.9%15.7%9.3 $15.10 12/31/20199,400,000 shares $112.89 million +6.7%17.4%10.9 $12.01 8/15/20193,660,200 shares $50.51 million -8.2%7.1%7.7 $13.80 CYTK Short Interest - Frequently Asked Questions What is Cytokinetics' current short interest? Short interest is the volume of Cytokinetics shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 16,420,000 shares of CYTK short. 14.86% of Cytokinetics' shares are currently sold short. Learn More on Cytokinetics' current short interest. What is a good short interest ratio for Cytokinetics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CYTK shares currently have a short interest ratio of 7.0. Learn More on Cytokinetics's short interest ratio. Which institutional investors are shorting Cytokinetics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cytokinetics: Walleye Trading LLC, Ikarian Capital LLC, Jane Street Group LLC, PEAK6 Investments LLC, HAP Trading LLC, XR Securities LLC, Concourse Financial Group Securities Inc., and Nomura Holdings Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Cytokinetics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.86% of Cytokinetics' floating shares are currently sold short. Is Cytokinetics' short interest increasing or decreasing? Cytokinetics saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 16,420,000 shares, an increase of 15.7% from the previous total of 14,190,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cytokinetics' float size? Cytokinetics currently has issued a total of 104,850,000 shares. Some of Cytokinetics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cytokinetics currently has a public float of 110,480,000 shares. How does Cytokinetics' short interest compare to its competitors? 14.86% of Cytokinetics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Cytokinetics: Avidity Biosciences, Inc. (11.31%), Phathom Pharmaceuticals, Inc. (44.10%), ORIC Pharmaceuticals, Inc. (16.09%), Nkarta, Inc. (16.69%), Karyopharm Therapeutics Inc. (16.17%), BioXcel Therapeutics, Inc. (3.94%), Alnylam Pharmaceuticals, Inc. (1.96%), Teva Pharmaceutical Industries Limited (1.61%), Genmab A/S (0.44%), Royalty Pharma plc (3.45%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks. What does it mean to sell short Cytokinetics stock? Short selling CYTK is an investing strategy that aims to generate trading profit from Cytokinetics as its price is falling. CYTK shares are trading up $1.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cytokinetics? A short squeeze for Cytokinetics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CYTK, which in turn drives the price of the stock up even further. How often is Cytokinetics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CYTK, twice per month. The most recent reporting period available is May, 31 2024. More Short Interest Resources from MarketBeat Related Companies: RNA Short Interest Data PHAT Short Interest Data ORIC Short Interest Data NKTX Short Interest Data KPTI Short Interest Data BTAI Short Interest Data ALNY Short Interest Data TEVA Short Interest Data GMAB Short Interest Data RPRX Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CYTK) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersDiscover How to Turn $10,000 into $1 MillionToday, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRIL...Paradigm Press | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...The Oxford Club | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredBUY ALERT: Tiny tech play partners with US governmentThe Federal Reserve is rolling out a powerful new financial technology across the entire U.S. banking system. ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytokinetics, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytokinetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.